Amy Pooler
Corporate Officer/Principal bij SANGAMO THERAPEUTICS, INC.
Vermogen: 83 993 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Amy Pooler
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 15 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Amy Pooler via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ANTARES PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | General Counsel | |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Medical Specialties | Comptroller/Controller/Auditor | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Doctorate Degree | |
| University of Bath | College/University | Undergraduate Degree | |
| Oxford Brookes University | College/University | Undergraduate Degree | |
| University of Salford | College/University | Graduate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree | |
Boron Molecular Ltd.
 Boron Molecular Ltd. Chemicals: Major DiversifiedProcess Industries Boron Molecular Ltd. manufactures fine chemicals. Its products include biaryls, boronic acid esters and acids, catalyst, cubanes, diborons, energy storage, halides, polymer, raft agents, and trifluoroborates. The company was founded in 2001 and is headquartered in Noble Park, Australia. | Chemicals: Major Diversified | Chief Executive Officer | |
| San Jose State University | College/University | Masters Business Admin | |
| University of California, Berkeley | College/University | Doctorate Degree Graduate Degree | |
| University of Delaware | College/University | Undergraduate Degree | |
| EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Warwick | College/University | Doctorate Degree | |
| The University of Western Australia | College/University | Doctorate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
XOMA (US) LLC
 XOMA (US) LLC Pharmaceuticals: MajorHealth Technology XOMA (US) LLC develops pharmaceutical preparations. It offers proprietary drugs and toiletries. The company is headquartered in Emeryville, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of New England (Australia) | College/University | Masters Business Admin | |
| FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
Humanetics Corp.
 Humanetics Corp. Pharmaceuticals: MajorHealth Technology Humanetics Corp. engages in development and commercialization of bioactive compounds. Its products include radiation modulators, mechanism of action, safety and toxicology, and pharmacokinetics. It focuses on oncology, medical imaging, and medical countermeasures. The company was founded by Ronald J. Zenk in 1988 and is headquartered in Edina, MN. | Pharmaceuticals: Major | Director/Board Member | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| 4D PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
| BEYOND AIR, INC. | Medical Specialties | Director/Board Member | |
Cour Pharmaceuticals Development Co., Inc.
 Cour Pharmaceuticals Development Co., Inc. BiotechnologyHealth Technology Cour Pharmaceuticals Development Co., Inc. engages in the development of therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. Its product pipeline include celiac disease, peanut allergy, multiple sclerosis, and neutralizing antibodies. The company was founded by John J. Puisis and Jim Herrmann and is headquartered in Chicago, IL. | Biotechnology | Director/Board Member | |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Biotechnology | Director/Board Member | |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Medical/Nursing Services | Chief Executive Officer | |
| Suburban Downs, Inc. | Director/Board Member | ||
| Curtin University of Technology | College/University | Undergraduate Degree | |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| ORGANOGENESIS HOLDINGS INC. | Medical Specialties | Director/Board Member | |
| EMYRIA LIMITED | Packaged Software | Director/Board Member | |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Eliminate Cancer, Inc. | Chief Executive Officer | ||
Beyond Cancer, Ltd.
 Beyond Cancer, Ltd. BiotechnologyHealth Technology Beyond Cancer, Ltd. is a development-stage biopharmaceutical and Bermudian medical device company that utilizes a proprietary delivery platform to treat primary tumors and prevent metastatic disease. The private company is based in Hamilton, Bermuda. Beyond Cancer is currently conducting a first-in-human study in patients with solid tumors and is focused on next level immuno-oncology. The CEO of the company is Selena A. Chaisson. | Biotechnology | Director/Board Member | |
| ACELYRIN, INC. | Pharmaceuticals: Major | Founder | |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 36 |
| Verenigd Koninkrijk | 7 |
| Australië | 5 |
| Denemarken | 2 |
| Ierland | 2 |
Sectoraal
| Health Technology | 31 |
| Consumer Services | 14 |
| Commercial Services | 2 |
| Process Industries | 2 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 64 |
| Corporate Officer/Principal | 31 |
| Independent Dir/Board Member | 25 |
| Chief Tech/Sci/R&D Officer | 11 |
| Undergraduate Degree | 10 |
Sterkste connecties
| Insiders | |
|---|---|
| Karen Smith | 29 |
| Robert Carey | 23 |
| H. Parker | 22 |
| Peg Horn | 12 |
| Kenneth Hillan | 10 |
| James Meyers | 9 |
| Alexander Macrae | 7 |
| John Markels | 7 |
| Prathyusha Durabaibu | 5 |
| Courtney Beers | 4 |
| Scott Willoughby | 3 |
| Nathalie Dubois Stringfellow | 2 |
| Louise Wilkie | 2 |
| Phillip Ramsey | 1 |
| Gregory Davis | 1 |
- Beurs
- Insiders
- Amy Pooler
- Bedrijfsconnecties
